Gilead Sciences, Inc. filed a UDRP complaint against David Czinczenheim over the domain gilead-us.com, which was being offered for sale for $995. The WIPO panel ordered the transfer of the domain, finding that it was registered and used in bad faith.
Case Snapshot
| Case Number | D2026-3100 |
|---|---|
| Complainant | Gilead Sciences, Inc. |
| Respondent | David Czinczenheim, prnator.com |
| Disputed Domain | gilead-us.com |
| Threat Tactic | Ransom or Resale |
| Decision Date | 2026-09-07 |
| Panelist | Sebastian M.W. Hughes |
| Outcome | Transfer |
| Official Source | https://www.wipo.int/amc/en/domains/search/text.jsp?case=D2026-3100 |
Facing Unauthorized Domain Registrations or Brand Abuse?
Our domain dispute attorneys represent trademark owners and businesses worldwide before WIPO, Forum (NAF), and CAC. Explore our Domain Name Disputes and Enforcement & Takedowns services, or request a free case evaluation.
Request Case EvaluationRisks of Domain Resale Tactics and Identity Obfuscation
The registration of gilead-us.com highlights a recurring business risk wherein bad-faith actors leverage high-value trademarks to extract illicit resale fees. By deploying a GoDaddy-hosted sales landing page with a fixed price of USD 995, the respondent attempted to commoditize Gilead Sciences’ intellectual property, forcing the brand owner to choose between initiating formal legal proceedings or paying a ransom for domain recovery. This tactic not only imposes direct financial costs on the brand owner but also forces the allocation of administrative and legal resources to address unauthorized assets that dilute the company’s digital footprint.
The operational security risks in this matter were compounded by the respondent’s use of privacy protection services to mask their identity. During the registrar verification process, discrepancies emerged between the contact details initially provided and the underlying ownership information disclosed to the WIPO Center. This deliberate obfuscation hinders initial investigation efforts and complicates the attribution of bad-faith intent. For organizations, this underscores the necessity of monitoring for trademark-inclusive domains early in their lifecycle, as the combination of typosquatting and subsequent resale attempts frequently serves as a bridge for further brand exploitation if not swiftly challenged through the UDRP process.
Panel Reasoning: Confusing Similarity, Legitimate Interests, and Bad Faith
The Panel confirmed that the disputed domain name, gilead-us.com, satisfies the threshold requirement of confusing similarity under the UDRP. By incorporating the GILEAD trademark in its entirety and appending a geographic suffix, the respondent created a domain name that is inherently associated with the complainant’s established global biopharmaceutical brand. The Panel applied the standard WIPO Overview 3.1 analysis, concluding that the first element of the Policy is met through this direct comparison between the trademarked mark and the infringing string.
Regarding the second element, the Panel examined whether the respondent held any rights or legitimate interests in the domain name under the criteria set forth in Paragraph 4(c) of the Policy. The evidence indicated an absence of any bona fide usage or credible connection between the respondent and the Gilead Sciences brand. The respondent failed to provide a formal rebuttal to the complainant’s contentions regarding its lack of rights, which, coupled with the nature of the domain name itself, led the Panel to determine that the respondent possesses no legitimate interest in the disputed property.
On the issue of bad faith, the Panel scrutinized the registration and use of the domain under Paragraph 4(a)(iii). The domain resolved to a GoDaddy-hosted sales landing page, where it was actively offered for purchase at a price of USD 995. This commercialization tactic, combined with the clear mimicry of the complainant’s primary digital presence, provided sufficient evidence that the domain was both registered and used in bad faith. The respondent’s failure to engage in the process—beyond a single informal email—further solidified the conclusion that the domain served as an instrument for unauthorized resale rather than any lawful business activity.
Strategic Drivers for Success in Gilead Sciences, Inc. v. David Czinczenheim
The complainant’s strategy effectively leveraged the respondent’s clear commercial intent to establish bad faith under the UDRP. By presenting evidence that the disputed domain name resolved to a GoDaddy-hosted sales page featuring a specific buy-it-now price of USD 995, the complainant successfully invoked the presumption of bad-faith registration and use. This provided a concrete factual basis for the panel to find that the respondent sought to capitalize on the reputation of the GILEAD trademark, rather than developing any legitimate commercial or non-commercial interest. The complainant’s approach demonstrated how straightforward price-based evidence can create an insurmountable hurdle for a respondent who offers no credible defense.
Procedural clarity and meticulous registrar verification further bolstered the complainant’s position. When the registrar’s verification response revealed that the registrant’s identity differed from the details initially provided in the complaint—specifically identifying an individual in France rather than the placeholder privacy service—the complainant was able to pivot quickly. The respondent’s failure to mount a substantive defense beyond a single preliminary email communication left the complainant’s evidence of confusing similarity and unauthorized trademark use uncontested. This procedural mismatch highlights the necessity of early and accurate registrar data gathering, which directly facilitates the panel’s ability to conclude that the respondent lacked rights or legitimate interests in the disputed domain.
Practical Recommendations
- Monitor registrar verification data for discrepancies between public Whois/Privacy service details and the actual registrant identity, as these often signal bad-faith intent.
- Document all ‘buy-it-now’ pricing and landing page screenshots immediately upon discovery to establish clear evidence of commercial bad-faith intent under UDRP policy.
- Leverage the absence of a formal, substantive response from a respondent as an indicator that the domain lacks legitimate interest or connection to the mark.
- Prioritize aggressive UDRP filings for domains that copy core brand identifiers, even at lower price points, to prevent long-term brand dilution and operational security risks.
- Verify that your legal team maintains a comprehensive registry of all global trademark filings to streamline the ‘standing’ requirement in UDRP proceedings.
Frequently Asked Questions (FAQ)
Why was the domain gilead-us.com considered confusingly similar to the GILEAD trademark?
The WIPO panel found that the disputed domain name incorporates the GILEAD trademark in its entirety and appends the suffix ‘-us’, which directly mimics the complainant’s official branding and operations for its U.S. market.
How did the respondent attempt to profit from the GILEAD trademark?
The respondent registered the domain and resolved it to a GoDaddy-hosted sales landing page, where it was publicly offered for sale at a ‘Buy now’ price of USD 995, clearly demonstrating commercial intent to profit from the complainant’s mark.
What evidence proved the respondent acted in bad faith?
Beyond the active solicitation for sale, the respondent provided no evidence of legitimate use and failed to formally address the complainant’s contentions, further supported by the respondent’s attempt to mask ownership through privacy services.
What was the outcome of the UDRP proceeding for Gilead Sciences?
The WIPO panel ruled in favor of Gilead Sciences, determining the domain was registered and used in bad faith, and subsequently ordered the transfer of the domain gilead-us.com to the complainant.
Facing a Domain Ransom Demand?
Don’t pay for your own brand. As seen in the Gilead Sciences case, we help organizations navigate UDRP proceedings to recover trademarked domains without ceding to unauthorized resale demands.
This case note is for informational purposes only and is not legal advice.
